title: Molecular Descriptors in Modelling the Tumour Necrosis Factor-α Converting Enzyme Inhibition Activity of Novel Tartrate-Based Analogues.
abstract: The tumour necrosis factor-α converting enzyme inhibition activity of a series comprising of novel tartrate-based analogues has been quantitatively analysed in terms of molecular descriptors. The statistically validated quantitative structure-activity relationship models provided rationales to explain the inhibition activity of these congeners. The descriptors identified through combinatorial protocol in multiple linear regression analysis have highlighted the role of Moran autocorrelation of lag 7, weighted by atomic van der Waals volume, presence of both prime and nonprime amide carbonyl oxygen in the tartrate moiety and occurrence of five membered ring bearing substituents at varying sites. A few potential novel tartrate-based analogues have been suggested for further investigation.
authors.affiliation: Department of Chemistry, S. K. Government Post Graduate College, Sikar-332 001, India.
authors.forename: P
authors.initials: P
authors.lastname: Singh
keywords: Combinatorial protocol in multiple linear regression analysis; inhibitors of tumour necrosis factor-α converting enzyme; molecular descriptors; novel tartrate-based compounds; quantitative structure-activity relationship
references.citation: SAR QSAR Environ Res. 2010 Jan 1;21(1):169-85
references.pmid: 20373219
references.citation: Nature. 1997 Feb 20;385(6618):729-33
references.pmid: 9034190
references.citation: Ann Rheum Dis. 2001 Nov;60 Suppl 3:iii25-32
references.pmid: 11890648
references.citation: Anal Chem. 2007 Jun 15;79(12):4538-42
references.pmid: 17500537
references.citation: SAR QSAR Environ Res. 2010 Apr;21(3-4):369-88
references.pmid: 20544556
references.citation: Nat Rev Drug Discov. 2003 Sep;2(9):736-46
references.pmid: 12951580
references.citation: Curr Opin Chem Biol. 2007 Oct;11(5):518-26
references.pmid: 17931956
references.citation: Environ Health Perspect. 2003 Aug;111(10):1361-75
references.pmid: 12896860
references.citation: Bioorg Med Chem. 2007 Sep 15;15(18):6170-81
references.pmid: 17606376
references.citation: Bioorg Med Chem Lett. 2008 Nov 1;18(21):5809-14
references.pmid: 18835710
references.citation: J Med Chem. 1999 Jul 1;42(13):2295-314
references.pmid: 10395470
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3408-12
references.pmid: 9520379
references.citation: Bioorg Med Chem. 2006 Jan 1;14(1):200-13
references.pmid: 16185882
references.citation: Clin Cancer Res. 2001 Jul;7(7):1912-22
references.pmid: 11448904
references.citation: Mol Divers. 2010 May;14(2):371-84
references.pmid: 19657719
references.citation: J Med Chem. 2009 Nov 12;52(21):6790-802
references.pmid: 19821586
references.citation: IDrugs. 2000 Mar;3(3):336-45
references.pmid: 16103944
references.citation: Nature. 1997 Feb 20;385(6618):733-6
references.pmid: 9034191
references.citation: J Clin Oncol. 1998 Jun;16(6):2150-6
references.pmid: 9626215
references.citation: Curr Med Chem. 2001 Mar;8(4):425-74
references.pmid: 11172697
references.citation: Bioorg Med Chem. 2006 Nov 1;14(21):7347-58
references.pmid: 16962784
references.citation: J Am Chem Soc. 2004 Dec 1;126(47):15495-503
references.pmid: 15563178
references.citation: Heart Fail Rev. 2004 Jan;9(1):63-79
references.pmid: 14739769
references.citation: Bioorg Med Chem Lett. 2008 Mar 1;18(5):1577-82
references.pmid: 18242982
references.citation: Bioorg Med Chem Lett. 2006 Mar 15;16(6):1605-9
references.pmid: 16426848
references.citation: Pharmacol Ther. 2008 Feb;117(2):244-79
references.pmid: 18155297
references.citation: J Pathol. 2008 Jan;214(2):149-60
references.pmid: 18161752
references.citation: Eur J Med Chem. 2008 Nov;43(11):2354-60
references.pmid: 18353509
references.citation: Ann N Y Acad Sci. 1999 Jun 30;878:228-35
references.pmid: 10415734
references.citation: Chem Biol. 2003 Mar;10(3):215-23
references.pmid: 12670535
references.citation: Bioorg Med Chem. 2007 May 15;15(10):3565-71
references.pmid: 17368033
references.citation: Nat Clin Pract Rheumatol. 2008 Jun;4(6):300-9
references.pmid: 18414459
references.citation: SAR QSAR Environ Res. 2011 Jun;22(3):365-83
references.pmid: 21598199
references.citation: J Med Chem. 1997 Dec 19;40(26):4347-59
references.pmid: 9435904
references.citation: Expert Opin Ther Targets. 2003 Feb;7(1):19-34
references.pmid: 12556200
references.citation: Bioorg Med Chem. 2009 Jan 15;17(2):444-59
references.pmid: 19095454
references.citation: Eur J Med Chem. 2009 Apr;44(4):1377-82
references.pmid: 18973967
references.citation: J Med Chem. 2008 Feb 28;51(4):725-36
references.pmid: 18247549
references.citation: J Bone Joint Surg Br. 1998 Sep;80(5):907-8
references.pmid: 9768907
references.citation: Bioorg Med Chem Lett. 2010 Feb 1;20(3):1189-93
references.pmid: 20022498
references.citation: Chem Rev. 1999 Sep 8;99(9):2735-76
references.pmid: 11749499